Reactivity of monoclonal antibodies to Pseudomonas aeruginosa isolates from hospitalized adults and patients with cystic fibrosis.

To assess the potential therapeutic use of three human monoclonal antibodies (MAbs) and one murine MAb, we tested the reactivity of these MAbs toward 100 clinical isolates of Pseudomonas aeruginosa. Seventy-five isolates were from hospitalized patients, while 25 were recovered from patients with documented cystic fibrosis. Nine isolates showed autoagglutination. The three human MAbs and one murine MAb exhibited agglutination with 81% of the P. aeruginosa isolates obtained from hospitalized patients and with 72% of the isolates from patients with cystic fibrosis. Eight of the autoagglutinating isolates were reactive in whole-cell ELISAs with the MAbs. The isolates recovered from patients with cystic fibrosis were reactive mainly with a MAb that is directed to the outer core of lipopolysaccharide (LPS); they showed hardly any reaction with O antigen-specific MAbs or typing sera, a finding indicating that these isolates lacked the O antigen and that the outer core of the LPS was still present. The reactivity of the MAb specific for the outer core of LPS toward P. aeruginosa isolates from patients with cystic fibrosis has potential value in eradicating P. aeruginosa from these patients.

[1]  G. Pier,et al.  Immune complexes from immunized mice and infected cystic fibrosis patients mediate murine and human T cell killing of hybridomas producing protective, opsonic antibody to Pseudomonas aeruginosa. , 1993, The Journal of clinical investigation.

[2]  K. Watanabe,et al.  Therapeutic effects of a human antiflagella monoclonal antibody in a neutropenic murine model of Pseudomonas aeruginosa pneumonia , 1993, Antimicrobial Agents and Chemotherapy.

[3]  S. Cryz,et al.  Affinity constants of naturally acquired and vaccine-induced anti-Pseudomonas aeruginosa antibodies in healthy adults and cystic fibrosis patients. , 1992, The Journal of infectious diseases.

[4]  C. Galanos,et al.  Antibody responses to lipid A, core, and O sugars of the Pseudomonas aeruginosa lipopolysaccharide in chronically infected cystic fibrosis patients , 1992, Journal of clinical microbiology.

[5]  J. Elborn,et al.  IgG antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis. , 1992, Archives of disease in childhood.

[6]  J. Verhoef,et al.  Monoclonal antibodies that identify gram-negative bacteria using the magnetic immunoluminescence assay , 1992 .

[7]  H. Noguchi,et al.  Variable cross-reactivity of Pseudomonas aeruginosa lipopolysaccharide-code-specific monoclonal antibodies and its possible relationship with serotype. , 1992, Journal of general microbiology.

[8]  S. Cryz,et al.  Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosis , 1991, The Lancet.

[9]  K. Irie,et al.  Inhibitory activity on bacterial motility and in vivo protective activity of human monoclonal antibodies against flagella of Pseudomonas aeruginosa , 1991, Infection and immunity.

[10]  K. Irie,et al.  A protective human monoclonal antibody directed to the outer core region of Pseudomonas aeruginosa lipopolysaccharide , 1991, Infection and immunity.

[11]  K. Irie,et al.  Broad-spectra human monoclonal antibodies that protect mice infected with Pseudomonas aeruginosa. , 1991, Antibiotics and chemotherapy.

[12]  M. Collins,et al.  Opsonic and protective activity of five human IgM monoclonal antibodies reactive with lipopolysaccharide antigen of Pseudomonas aeruginosa. , 1990, FEMS microbiology immunology.

[13]  M. Stebbins,et al.  Generation and characterization of murine antiflagellum monoclonal antibodies that are protective against lethal challenge with Pseudomonas aeruginosa , 1990, Infection and immunity.

[14]  N. Sigal,et al.  A human monoclonal antibody that protects mice against Pseudomonas-induced pneumonia. , 1990, The Journal of infectious diseases.

[15]  K. Amako,et al.  Morphological evidence for penetration of anti-O antibody through the capsule of Klebsiella pneumoniae , 1990, Infection and immunity.

[16]  U. Schaad,et al.  Serotype-Specific Serum IgG Antibodies to Lipopolysaccharides of Pseudomonas aeruginosa in Cystic Fibrosis: Correlation to Disease, Subclass Distribution, and Experimental Protective Capacity , 1990, Pediatric Research.

[17]  Y. Knirel.  Polysaccharide antigens of Pseudomonas aeruginosa. , 1990, Critical reviews in microbiology.

[18]  J. Larrick,et al.  Isolation and characterization of a human monoclonal antibody that recognizes epitopes shared by Pseudomonas aeruginosa immunotype 1, 3, 4, and 6 lipopolysaccharides , 1989, Infection and immunity.

[19]  R. Bram,et al.  Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses. , 1989, The Journal of clinical investigation.

[20]  J. Pennington,et al.  Treatment of experimental Pseudomonas aeruginosa pneumonia with a human IgM monoclonal antibody. , 1989, The Journal of infectious diseases.

[21]  H. Noguchi,et al.  Heterogeneity of the L-rhamnose residue in the outer core of Pseudomonas aeruginosa lipopolysaccharide, characterized by using human monoclonal antibodies , 1989, Infection and immunity.

[22]  A. Kropinski,et al.  Occurrence of a common lipopolysaccharide antigen in standard and clinical strains of Pseudomonas aeruginosa , 1989, Journal of clinical microbiology.

[23]  J. Merrick,et al.  Effect of oral immunization with Pseudomonas aeruginosa on the development of specific antibacterial immunity in the lungs , 1989, Infection and immunity.

[24]  G. Pier,et al.  In vitro and in vivo activity of polyclonal and monoclonal human immunoglobulins G, M, and A against Pseudomonas aeruginosa lipopolysaccharide , 1989, Infection and immunity.

[25]  R. Hancock,et al.  Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains , 1983, Infection and immunity.

[26]  G. Bodey,et al.  Infections caused by Pseudomonas aeruginosa. , 1983, Reviews of infectious diseases.